Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
RVNC | Revance Therapeutics, Inc. | Director | $0 | Feb 4, 2025 | ||
ACLX | Arcellx, Inc. | Director | May 29, 2025 | |||
CTNM | Contineum Therapeutics, Inc. | Director | Jun 26, 2025 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|